SCHEMBL31240486

SCHEMBL31240486

Nc1n[nH]c2ccc(-c3ccnc4[nH]c(-c5ccccc5O)cc34)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK2 P49760 11/20 0.55
▸ DYRK1A Q13627 11/20 0.55
▸ CLK3 P49761 9/20 0.55
▸ JAK2 O60674 4/20 0.50
▸ JAK1 P23458 1/20 0.50
▸ TYK2 P29597 1/20 0.50
▸ JAK3 P52333 1/20 0.50
▸ CCNB2 O95067 1/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CCNB1 P14635 1/20 0.49
▸ GSK3A P49840 1/20 0.49
▸ GSK3B P49841 1/20 0.49
▸ CDK5 Q00535 1/20 0.49
▸ CDK5R1 Q15078 1/20 0.49
▸ CCNB3 Q8WWL7 1/20 0.49
▸ CHUK O15111 1/20 0.45
▸ INSR P06213 1/20 0.45
▸ MAPK8 P45983 1/20 0.45
▸ CAMKK2 Q96RR4 1/20 0.45
▸ RIPK1 Q13546 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240405 0.86 CLK2 (0.59) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240700 0.86 CLK2 (0.58) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240413 0.84 CLK2 (0.50) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240683 0.84 DYRK1A (0.54) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240705 0.84 CLK2 (0.57) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240376 0.83 CLK2 (0.62) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL26888731 0.83 CLK2 (0.51) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240458 0.83 CHUK (0.51) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240343 0.82 CLK2 (0.63) CLK2DYRK1ACLK3JAK2JAK1
SCHEMBL31240587 0.81 CLK2 (0.56) CLK2DYRK1ACLK3JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback